Approval · Notice of Compliance 26082 · 2021
JAMP VANCOMYCIN: Notice of Compliance 26082
Issued June 17, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26082
- Date
- June 17, 2021
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- VANCOCIN (Merus Labs International Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP VANCOMYCIN | 02407744 | Marketed |
| JAMP VANCOMYCIN | 02407752 | Marketed |
Medicinal ingredients
- VANCOMYCIN 125 MG per CAP
- VANCOMYCIN 250 MG per CAP